When you buy through links on our articles, Future and its syndication partners may earn a commission. A new blood-based test for colorectal cancer is designed to screen for cancer-related DNA ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

The test, which screens for DNA that is released when cancer cells die, is now one of multiple options for colorectal cancer screening. Guardant Health's Shield blood test for colorectal cancer ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, demonstrating high sensitivity for both malignant and advanced precancerous lesions ...

The newest version of Cologuard, an at-home colon cancer screening test, results in fewer false positives that can lead to ...

A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...

The American Cancer Society recommends that people at average risk of colorectal cancer start regular screening at age 45, and several blood tests on the market could help. These tests are done in a ...

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...

ERROL MITROPOULOS JOINS US NOW WITH MORE ARIELLE. MONICA. DOCTORS WANT TO MAKE IT VERY CLEAR THAT THIS ISN’T REPLACING COLONOSCOPIES, BUT THEY’RE HOPEFUL THAT THIS MAY MAKE MORE PEOPLE GET SCREENED.

The Food and Drug Administration (FDA) has recently approved a blood test that can assist in the primary detection of colorectal cancer. This test could assist with prompt detection and intervention ...